Completed
Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
NCT00634452
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphomas, +7 more
- Locations
-
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- ClinWorks Cancer Research Center Charlotte, North Carolina, United States